SAIR: Accelerating Pharma R&D with AI-Powered Structural Intelligence
Analysis
Key Takeaways
- •AI is being used to accelerate pharmaceutical R&D.
- •SAIR is a key technology in this process, leveraging structural intelligence.
- •The goal is to improve efficiency and success rates in drug discovery.
“Further details about the specific AI models and their applications in drug discovery would be beneficial.”